Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Discovery of steroid sulphatase inhibitors recognised with GSK award

The achievements of two researchers who contributed to the discovery of steroid sulphatase inhibitors were recognised earlier this week at the British Pharmaceutical Conference held in Manchester from 6 to 9 September 2009.

Barry Potter, professor of medicinal and biological chemistry at the University of Bath, and the late Michael Reed, professor of steroid biochemistry at Imperial College, London, won the 2009 GlaxoSmithKline International Achievement Award.   

The award was presented in recognition of their contribution to the discovery of steroid sulphatase inhibitors, being investigated in clinical trials as anticancer agents by Ipsen.

Professor Potter said: “Winning the GSK International Achievement Award is a great honour and a most welcome recognition of the interdisciplinary work that Professor Reed and I have led for almost two decades. Modern clinical drug discovery is a team effort and rarely achieved in academia. We accept this award also on behalf of other talented scientific colleagues at both institutions whose contributions are warmly acknowledged.”

Professor Potter delivered a lecture, entitled “Steroid sulphatase inhibitors: from concept to clinic”, at the conference, a report from which will appear in the BPC supplement to be distributed with The Pharmaceutical Journal in October.

Citation: The Pharmaceutical Journal URI: 10977876

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.


Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.